Examining the conspicuousness and prominence of two required warnings on OTC pain relievers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 16, 2009, Pages 6550-6555

  Bix, Laura ^a   Bello, Nora M ^b   Auras, Rafael ^a   Ranger, Jon ^a   Lapinski, Maria K ^b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Conspicuous; Drug labels; Labeling; OTC drugs; Prominent

Indexed keywords

ANALGESIC AGENT; NON PRESCRIPTION DRUG;

ARTICLE; AWARENESS; CONTROLLED STUDY; DRUG INFORMATION; DRUG LABELING; DRUG PACKAGING; EVALUATION; EYE TRACKING; FEMALE; HUMAN; MALE; PAIN; PRIORITY JOURNAL; PUPIL; RECALL; UNITED STATES; ADULT; METHODOLOGY; MIDDLE AGED; PHOTOSTIMULATION; PRESCHOOL CHILD; READING; SHORT TERM MEMORY; STANDARD; TIME;

ADULT; ANALGESICS; CHILD, PRESCHOOL; DRUG LABELING; DRUG PACKAGING; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NONPRESCRIPTION DRUGS; PHOTIC STIMULATION; READING; TIME FACTORS;

EID: 66149156265     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0810665106     Document Type: Article

References (52)

1. Rousseau G, Lamson N, Rodgers W (1998) Designing warnings to compensate for age-related changes in perceptual and cognitive abilities. Psychol Mark 15:643-662.
2. Food and Drug Administration (1997) Over-the-counter human drugs: Proposed labeling requirements. 62 Federal Register 39 (1997), pp 9024-9062.
3. Sansgiry S, Cady P, Shubhada P (1997) Readability of over-the-counter medication labels. J Am Pharm Assoc 37:522-528.
4. Wechsler J (1991) Information please: Patient education as a cost cutter. Pharma Exec 11(7):16-19.
5. Food and Drug Administration (1999) Over-the-counter Human drugs: Labeling requirement. Final rule. Fed Regist 64:13254-13303.
6. Alsobrook H (1992) An overview of liability for OTC drugs. Drug Info J 26:317-328.
7. Davis T, et al. (2006) Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med 21:847-851.
8. Davis T, et al. (2006) Literacy and misunderstanding prescription drug labels. Ann Intern Med 145:887-895.
9. Gore P, Madhavan S, McClung G, Riley D (1994) Consumer involvement in nonprescription medicine purchases. J Health Care Mark 14:16-23.
10. Kalsher M, Wogalter M, Racicot B (1996) Pharmaceutical container labels: Enhancing preference perceptions with alternative designs and pictorials. Int J Ind Ergon 18:83-90.
11. Lehto M, Miller J (1988) The effectiveness of warning labels. J Prod Liability 11:225-270.
12. Lumpkin J, Strutton D, Lim C, Lowrey S (1990) A shopping orientation based prescription for the treatment of OTC medication misuse among the elderly. Health Marke Q 8:95-110.
13. Mansoor L, Dowse R (2004) Design and evaluation of a new pharmaceutical pictogram sequence to convey medicine usage. J Ergon Soc S Afr 16(2):29-41.
14. Rogers W, Rousseau G, Lamson N (1999) Maximizing the Effectiveness of the Warning Process: Understanding the Variables That Interact with Age , eds Park DC, Roger W, Morrell R, Shifren K, Park D (Psychology Press, London).
15. Morrow D, Leier V (1999) Designing medication instructions for older adults. In: Park D, Morrell R, Shifren K, eds, Processing of Medical Information in Aging Patients (Lawrence Erlbaum and Associates, London).
16. Nabors L, Lehmkuhl H, Parkins I, Drury A (2004) Reading about over-the-counter medications. Issues Compr Pediatr Nursing 27:297-305.
17. Reisenwitz T, Wimbish J (1997) The purchase decision process and involvement of the elderly regarding nonprescription products. Health Mark Q 15:49-68.
18. Robinson D, Stewart R (1981) Elderly: Understanding their prescription needs. Am Pharm 21:48.
19. Rogers W, Rousseau G, Lamson N (1998) Maximizing the effectiveness of the warning process: Understanding the variables that interact with age. In: Morrell R, Park D, eds, Aging and Medication Information Processing .
20. Roumie C, Griffin M (2004) Over-the-counter analgesics in older adults: A call for improved labelling and consumer education. Drugs Aging 21:485-498.
21. Rousseau G, Lamson N, Rogers W (1998) Designing warnings to compensate for age-related changes in perceptual and cognitive abilities. Psychol Mark 15:643-662.
22. Sansgiry S, Cady P (1996) Can picture use effectively enhance the understanding of nonprescription drug labels in older adults? J Geriatr Drug Ther 10:51-69.
23. Sansgiry S, Cady P (1996) How the elderly and young adults differ in the decision making process of nonprescription medication purchases. Health Mark Q 14:3-22.
24. Sansgiry S, Cady P, Sansgiry S (2001) Consumer involvement: Effect on information processing from over-the-counter medication labels. Health Mark Q 19:61-78.
25. Tennesen M (1999) Before you play doctor. Health Mark Q 13:98-100,102-103.
26. Vanderplas J, Vanderplas J (1980) Some factors affecting legibility of printed materials for older adults. Percept Mot Skills 50:923-932.
27. Wogalter MS, Dietrich DA (1995) Enhancing label readability for over-the-counter pharmaceuticals by elderly consumers. Proceedings of the Human Factors and Ergonomics Society 39th Annual Meeting 1995 (HFES, Santa Monica, CA), pp 143-147.
28. Wogalter M, Magurno A, Scott K, Dietrich D (1996) Facilitating information acquistion for over-the-counter drugs using supplemental labels. Proceedings of the Human Factors and Ergonomics Society 40th Annual Meeting 1996 (HFES, Santa Monica, CA), pp. 732-736.
29. Bix L (1998) The effect of subject age on legibility. MSc thesis. Michigan State Univ (East Lansing, MI).
30. Bix L (2001) Toward a performance standard for typeface legibility: The lockhart legibility instrument. PhD dissertation. Michigan State Univ (East Lansing, MI).
31. Bojko A, Buffardi K, Lew G, Israelski E (2006) Eye tracking study on the impact of the manufacturer's logo and multilingual descrption on drug selection performance. Proceedings of the Human Factors and Ergonomics Society 50th Annual Meeting 2006 (HFES, Santa Monica, CA), pp 1112-1116.
32. Bojko A, Gaddy C, Lew G, Quinn A, Israelski E (2005) Evaluation of drug label designs using eye tracking. Proceedings of the Human Factors and Ergonomics Society 49th Annual Meeting 2005 (HFES, Santa Monica, CA), pp 1033-1037.
33. Harris Interactive Market Research Firm (January 2002) (Prepared for the National Council on Patient Information and Education). Attitudes and beliefs about the use of over-the-counter medicines: A dose of reality. Available at http://www.bemedwise.org/ survey/final-survey.pdf. Accessed March 3, 2009.
34. Johnson M, Drungle S (2000) Purchasing over-the-counter medications: The influence of age and familiarity. Exp Aging Res 26:245-261.
35. Food and Drug Administration (2005) Guidance for the Industry: Labeling OTC Human Drug Products Questions and Answers .
36. Food and Drugs Chapter I Subchapter C. Tamper-Evident Packaging Requirements for Over-The-Counter (OTC) Human Drug Products. 63 Federal Register 213 (1998), pp 59463-59471.
37. Poison Prevention Packaging Act. Public L no. 91-601, 84 Stat 1670 (1970).
38. Food and Drug Administration (2006) Compliance with section 301 of the Medical Device User Fee and Modernization Act of 2002, as amended: Prominent and conspicuous mark of manufacturers on single-use devices. Available at http://www.fda.gov/ CDRH/comp/guidance/1217.html. Accessed March 10, 2009.
39. Food and Drug Administration. Drugs and Devices; National Drug Code Numbers. 21 Code of Federal Regulations 75, section 201.2, pp 143-144.
40. Medical Device User Fee and Modernization Act of 2002, Public Law 107-250 (116 Stat, 1588-162) Section 302.
41. Alcohol Labeling Beverage Act of 1988. 27 USC Chapter 8 Subchapter II Subsection 215 (1998).
42. Environmental Protection Agency 40 Code of Federal Regulations 23, section 156.10, pp 61-67. Revised as of July 1, 2008.
43. Food and Drug Administration 21 Code of Federal Regulations 4, section 201.15, pp 14-15. Revised as of April 1, 2008.
44. Boston University Epidemiology Center (2004) The Slone Survey: Patterns of Medication Use in the United States (Boston Univ, Boston).
45. Boston University Epidemiology Center (2005) The Slone Survey: Patterns in Medication Use in the United States (Boston Univ, Boston)
46. Boston University Epidemiology Center (2006) The Slone Survey: Patterns of Medication Use in the United States: A Report from the Slone Survey (Boston Univ, Boston).
47. Fair Packaging and Labeling Act of 1966. Public Law 89-755. Title 15; Chapter 39. USC (1966).
48. U.S. Consumer Products Safety Commission (1999) Poison Prevention Packaging: A Text for Pharmacists and Physicians . Available at http://www.cpsc.gov/cpscpub/pubs/ 384.pdf. Accessed March 10, 2009.
49. Young S (2007) Applying an architecture: Label viewing patterns suggest easy ways to prioritize package messages. Package Design Magazine . Available at http:// www.packagedesignmag.com/cgi-bin. Accessed March 10, 2009.
50. Vigilante W, Wogalter M (1997) The preferred order of over-the-counter (OTC) pharmaceutical label components. Drug Inf J 31:973-988.
51. Kou EY (2006) Child Resistant Drug Packaging and Arthritis: Can Older Consumers Access Their Medications? (Michigan State Univ, East Lansing, MI).
52. National SAFE KIDS Campaign (NSKC) (2004) Poisoning Fact Sheet . Available at http:// www.preventinjury.org/PDFs/POISONING.pdf. Accessed March 10, 2009.